title: The drugs don't work? antidepressants and the current and future pharmacological management of depression.
abstract: Depression is a potentially life-threatening disorder affecting millions of people across the globe. It is a huge burden to both the individual and society, costing over £9 billion in 2000 alone: the World Health Organisation (WHO) cited it as the third leading cause of global disability in 2004 (first in the developed world), and project it will be the leading cause by 2030. The serendipitous discovery of antidepressants has revolutionized both our understanding and management of depression: however, their efficacy in the treatment of depression has long been debated and recently been brought very much into the public limelight by a controversial publication by Kirsch, in which the role of placebo response in antidepressant efficacy trials is highlighted. Whilst antidepressants offer benefits in both the short and long term, important problems persist such as intolerability, delayed therapeutic onset, limited efficacy in milder depression and the existence of treatment-resistant depression.
authors: Cognition, Schizophrenia and Imaging Laboratory, Department of Psychological Medicine, The Institute of Psychiatry, King's College, London SE5 8AF, UK.
authors: Elizabeth
authors: E
authors: Penn
authors: Derek K
authors: DK
authors: Tracy
keywords: antidepressants; depression
references: JAMA. 2010 Jan 6;303(1):47-53
references: 20051569
references: Psychother Psychosom. 2008;77(1):17-26
references: 18087204
references: Br J Psychiatry. 2007 Aug;191:164-9
references: 17666502
references: Science. 2003 Jul 18;301(5631):386-9
references: 12869766
references: Neuropsychopharmacology. 2012 Mar;37(4):851-64
references: 22169941
references: BMJ. 2005 Jul 16;331(7509):155-7
references: 16020858
references: Lancet. 1997 Mar 29;349(9056):915-9
references: 9093253
references: Psychol Sci Public Interest. 2002 Nov;3(2):39-77
references: 26151569
references: Nat Neurosci. 2002 Nov;5 Suppl:1068-70
references: 12403988
references: Am J Psychiatry. 2009 Feb;166(2):140-5
references: 19188290
references: Arch Gen Psychiatry. 2011 Dec;68(12):1218-26
references: 22147841
references: Arch Gen Psychiatry. 2000 Apr;57(4):311-7
references: 10768687
references: Psychopharmacol Bull. 1993;29(2):175-81
references: 8290662
references: Int Clin Psychopharmacol. 2009 Nov;24(6):277-88
references: 19738481
references: J Clin Psychiatry. 2003 Apr;64(4):403-7
references: 12716240
references: Am J Psychiatry. 2009 May;166(5):599-607
references: 19339358
references: Ann Fam Med. 2005 Sep-Oct;3(5):449-56
references: 16189062
references: Lancet. 2003 Feb 22;361(9358):653-61
references: 12606176
references: J Clin Psychiatry. 2012 Apr;73(4):518-25
references: 22226407
references: Am J Psychiatry. 2007 Sep;164(9):1356-63
references: 17728420
references: Neuropsychopharmacology. 2003 Sep;28(9):1562-71
references: 12838272
references: Cochrane Database Syst Rev. 2009 Apr 15;(2):CD006117
references: 19370626
references: Cochrane Database Syst Rev. 2004;(1):CD003012
references: 14974002
references: Arch Gen Psychiatry. 1992 Oct;49(10):769-73
references: 1417428
references: Arch Gen Psychiatry. 2006 Nov;63(11):1217-23
references: 17088502
references: J Psychopharmacol. 2008 Jun;22(4):343-96
references: 18413657
references: Int J Neuropsychopharmacol. 2011 Apr;14(3):405-12
references: 20800012
references: Int Clin Psychopharmacol. 2006 Feb;21 Suppl 1:S21-4
references: 16436936
references: JAMA. 2002 Apr 10;287(14):1840-7
references: 11939870
references: Am J Psychiatry. 2003 Feb;160(2):237
references: 12562566
references: Arch Gen Psychiatry. 1992 Oct;49(10):809-16
references: 1417434
references: Control Clin Trials. 1994 Aug;15(4):244-6
references: 7956265
references: Psychiatry Res. 2009 Sep 30;169(2):124-31
references: 19712979
references: BMJ Clin Evid. 2011 May 25;2011:
references: 21609510
references: Biol Psychiatry. 2002 Jan 15;51(2):183-8
references: 11822997
references: BMJ. 2005 Feb 19;330(7488):396
references: 15718539
references: N Engl J Med. 2007 Jun 7;356(23):2343-6
references: 17485726
references: Mol Psychiatry. 2004 Apr;9(4):386-92
references: 15042104
references: Science. 1998 Sep 11;281(5383):1640-5
references: 9733503
references: J Psychiatry Neurosci. 2004 May;29(3):208-18
references: 15173897
references: Neuroreport. 2000 Jan 17;11(1):215-9
references: 10683861
references: J Clin Psychopharmacol. 2002 Feb;22(1):40-5
references: 11799341
references: Am J Psychiatry. 1990 Feb;147(2):207-10
references: 2301661
references: Neuropsychopharmacology. 2006 Apr;31(4):689-99
references: 16395296
references: J ECT. 2006 Mar;22(1):13-7
references: 16633200
references: Int J Neuropsychopharmacol. 2010 Feb;13(1):31-44
references: 19341510
references: J Clin Psychopharmacol. 2002 Dec;22(6):610-4
references: 12454561
references: Science. 2003 Aug 8;301(5634):805-9
references: 12907793
references: Arch Gen Psychiatry. 2012 Jun;69(6):580-7
references: 22309973
references: Evid Based Ment Health. 2008 Aug;11(3):66-8
references: 18669671
references: Am J Psychiatry. 2000 Mar;157(3):327-37
references: 10698806
references: Lancet. 2009 Feb 28;373(9665):746-58
references: 19185342
references: Nat Rev Neurosci. 2006 Feb;7(2):137-51
references: 16429123
references: Cochrane Database Syst Rev. 2009 Apr 15;(2):CD006532
references: 19370639
references: Acta Psychiatr Scand. 2012 Jun;125(6):453-9
references: 22176585
references: PLoS Med. 2008 Feb;5(2):e45
references: 18303940